Show summary Hide summary
A new analysis of U.S. death records shows cancer mortality has fallen substantially nationwide, but the benefits are unevenly distributed—concentrated in wealthy, coastal metropolitan areas while many rural and low-income counties have seen far smaller gains. That growing geographic divide matters now because it points to unequal access to prevention, screening and treatment that could shape health outcomes for years to come.
The study, published recently in the British Journal of Cancer, examined death-certificate records held in the CDC’s WONDER database. Researchers from Mississippi State University’s Social Science Research Center and Oak Ridge National Laboratory reviewed nearly four decades of data, covering almost 3,000 counties and more than 21 million cancer deaths from 1981 through 2019.
Overall improvement was clear: cancer mortality in the United States dropped by roughly 32% between 1991 and 2019. But that national average masks sharp local differences.
US to restart nonstop commercial flights to Caracas after 7-year pause
MLB contenders on the brink: 3 teams must solve key problems before playoff push
Where progress accelerated — and where it stalled
The largest reductions in deaths were seen in major urban centers, especially along the Atlantic and Pacific coasts, and in higher-income counties. In contrast, many interior and rural counties recorded much smaller declines.
Lead author Michael Cosby and colleagues describe a widening gap over time. By 2019 the counties in the top decile of income experienced roughly seven times the mortality improvement seen in the lowest-income decile — a striking divergence that persisted across regions.
Manhattan offers a concrete example of how targeted public health measures can change outcomes: the borough’s lung cancer mortality fell from about 49 deaths per 100,000 people in 1991 to 19.6 per 100,000 in 2019 — a reduction of roughly 60% tied in part to aggressive tobacco control policies.
Why the gaps likely exist
Researchers point to several plausible contributors that vary by place:
- Declining tobacco use: Stronger tobacco control in some cities appears to have driven substantial drops in lung cancer deaths.
- Access to screening and treatment: Faster adoption of screening programs and advanced therapies in wealthier, urban settings likely spurred earlier detection and better survival.
- Environmental and lifestyle factors: Differences in exposure to pollutants and in diet, exercise, and other behaviors may influence local trends.
These factors, the authors note, do not operate independently. Places that invested earlier in public-health measures and clinical services tended to reap bigger mortality reductions.
Limits of the analysis
The study is county-level and therefore cannot identify what happened to specific individuals — an important caveat when interpreting the results. The authors also acknowledge that unmeasured variables such as individual health behaviors, insurance coverage and local healthcare capacity could affect outcomes.
- Ecological limitation: County trends don’t prove individual risk or benefit.
- Missing variables: Factors like screening rates, treatment availability and individual socioeconomic status were not directly measured.
- Temporal shifts: Changes in population composition or migration could influence county-level statistics over decades.
Despite those constraints, the research signals a clear policy challenge: improvements in cancer survival are not occurring evenly across the country.
Cosby and his co-authors argue that variable speeds in adopting life-saving interventions—screening, anti-tobacco measures and modern therapies—may be widening geographic disparities even as mortality falls almost everywhere. They call for follow-up studies that examine local contributors in greater detail so interventions can be targeted where they are most needed.
For readers, the takeaway is practical as well as policy-oriented: local access to prevention and care matters. Identifying and closing gaps in screening, tobacco-control efforts and treatment availability could narrow the divide and ensure more communities share in the national decline in cancer deaths.
